Ultrarapid staining for cutaneous melanoma: Study and protocol

Dermatologic Surgery

Volumn 31, Issue 7 PART I, 2005, Pages 753-757

  Davis, Daniel A ^a   Kurtz, Kevin A ^b   Robinson, Robert A ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AZURE B; HMB 45 ANTIBODY; MELAN A ANTIBODY; S 100 ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FROZEN SECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; SKIN TUMOR; STAINING; COMPARATIVE STUDY; METHODOLOGY; PATHOLOGY;

FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; SKIN NEOPLASMS;

EID: 23344448825     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2005.31704     Document Type: Article

References (36)

1. Mohs FE. Chemosurgery for melanoma. Arch Dermatol 1977;113:285-91.
2. Zitelli JA, Mohs FE, Larson P, Snow S. Mohs micrographic surgery for melanoma. Dermatol Clin 1989;7:833-43.
3. Zitelli JA, Moy RL, Abell E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. J Am Acad Dermatol 1991;24:102-6.
4. Dzubow LM. Mohs surgery and malignant melanoma. Dermatol Surg 1995;21:283.
5. Brown CD, Zitelli JA. The prognosis and treatment of true local cutaneous recurrent malignant melanoma. Dermatol Surg 1995;21:285-90.
6. Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 1997;37(2 Pt 1):236-45.
7. Carucci JA. Mohs' micrographic surgery for the treatment of melanoma. Dermatol Clin 2002;20:701-8.
8. Prieto VG, Argenyi ZB, Barnhill RL, et al. Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions? Am J Clin Pathol 2003;120:203-8.
9. Bhawan J. Mel-5: a novel antibody for differential diagnosis of epidermal pigmented lesions of the skin in paraffin-embedded sections. Melanoma Res 1997;7:43-8.
10. Gross EA, Andersen WK, Rogers GS. Mohs micrographic excision of lentigo maligna using Mel-5 for margin control. Arch Dermatol 1999;135:15-7.
11. Zalla MJ, Lim KK, Dicaudo DJ, Gagnot MM. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg 2000;26:771-84.
12. Ruck P. Envision™ for rapid immunostaining in intraoperative frozen section diagnosis. Available at: http://www.dakocytomation. com/dakofacts_2.pdf p6.
13. Kammerer U, Kapp M, Gassel AM, et al. A new rapid immunohistochemical staining technique using the EnVision antibody complex. J Histochem Cytochem 2001;49:623-30.
14. Muna NM, Marcus S, Smart C. Detection by immunofluorescence of antibodies specific for human malignant melanoma cells. Cancer 1969;23:88-93.
15. Richter T, Nahrig J, Komminoth P, et al. Protocol for ultrarapid immunostaining of frozen sections. J Clin Pathol 1999;52:461-3.
16. Nahrig JM, Richter T, Kuhn W, et al. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry. Breast J 2003;9:277-81.
17. Griego RD, Zitelli JA. Mohs micrographic surgery using HMB-45 for a recurrent acral melanoma. Dermatol Surg 1998;24:1003-6.
18. Blessing K, Sanders DS, Grant JJ. Comparison of immunohistochemical staining of the novel antibody Melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 1998;32:139-46.
19. Fetsch PA, Marincola FM, Filie A, et al. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration. Cancer 1999;87:37-42.
20. Busam KJ, Jungbluth AA. Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol 1999;6:12-8.
21. Heegaard S, Jensen OA, Prause JU. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45. Melanoma Res 2000;10:350-4.
22. Orchard GE. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies Melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma. Histochem J 2000;32:475-81.
23. Shidham VB, Qi DY, Acker S, et al. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45. Am J Surg Pathol 2001;25:1039-46.
24. Xu X, Chu AY, Pasha TL, et al. Immunoprofile of MITF, tyrosinase, Melan-A, and MAGE-1 in HMB45-negative melanomas. Am J Surg Pathol 2002;26:82-7.
25. Snyder ML, Paulino AF. Melan-A as a useful diagnostic immunohistochemical stain for the diagnosis of primary sinonasal melanomas. Head Neck 2002;24:52-5.
26. Sheffield MV, Yee H, Dorvault CC, et al. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clin Pathol 2002;118:930-6.
27. Mahmood MN, Lee MW, Linden MD, et al. Diagnostic value of HMB-45 and anti-Melan A staining of sentinel lymph nodes with isolated positive cells. Mod Pathol 2002;15:1288-93.
28. Koch B, Eberhardt B, Westerhausen M. Azure B-eosin APAAP staining: a method for simultaneous hematological and immunological cell analysis. Biotechn Histochem 1995;70:267-70.
29. Kamino H, Tam ST. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms. J Cutan Pathol 1991;18:436-9.
30. Kligora CJ, Fair KP, Clem MS, Patterson JW. A comparison of melanin bleaching and azure blue counterstaining in the immunohistochemical diagnosis of malignant melanoma. Mod Pathol 1999;12:1143-7.
31. Bussolati G, Gugliotta P, Volante M, et al. Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry. Histopathology 1997;31:400-7.
32. Nayler SJ, Goetsch S, Cooper K. Biotin inclusions: a potential pitfall in immunohistochemistry. Histopathology 1998;33:87.
33. Zachary CB, Rest EB, Furlong SM, et al. Rapid cytokeratin stains enhance the sensitivity of Mohs micrographic surgery for squamous cell carcinoma. J Dermatol Surg Oncol 1994;20:530-5.
34. Menaker GM, Chiang JK, Tabila B, Moy RL. Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma. J Am Acad Dermatol 2001;44:833-6.
35. Albertini JG, Elston DM, Libow LF, et al. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Dermatol Surg 2002;28:656-65.
36. Kelley LC, Starkus L. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1. J Am Acad Dermatol 2002;46:78-84.